Literature DB >> 3437749

The effects of pentobarbital, fentanyl-droperidol, ketamine-xylazine and ketamine-diazepam on noxious stimulus perception in adult male rats.

S K Wixson1, W J White, H C Hughes, W K Marshall, C M Lang.   

Abstract

The increased use of rats for laboratory studies has increased the urgency for a better understanding of their perception of painful or noxious stimuli and the means of obtunding such stimuli. Four different injectable drugs, pentobarbital, fentanyl-droperidol (Innovar-Vet), ketamine-xylazine and ketamine-diazepam, were evaluated in this study. Unlike previous studies in rodents, this study has quantitated noxious stimulus perception following a temporal sequence of observations. Results showed the greatest inhibition of noxious stimulus perception with Innovar-Vet, lesser inhibition with ketamine-xylazine and ketamine-diazepam, and the least obtunding of nociception with pentobarbital. Results of this study also suggested that a spatial orientation, similar to that present in man, exists within the CNS of rats for receipt of noxious stimulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3437749

Source DB:  PubMed          Journal:  Lab Anim Sci        ISSN: 0023-6764


  4 in total

1.  Evaluation of Analgesic Efficacy of Meloxicam and 2 Formulations of Buprenorphine after Laparotomy in Female Sprague-Dawley Rats.

Authors:  Elizabeth A Nunamaker; Julia L Goldman; Cynthia R Adams; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-08-09       Impact factor: 1.232

2.  Deleterious impact of a γ-aminobutyric acid type A receptor preferring general anesthetic when used in the presence of persistent inflammation.

Authors:  Kevin Boegel; Ferenc E Gyulai; Kerry K Moore; Michael S Gold
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

3.  Isoflurane, ketamine-xylazine, and urethane markedly alter breathing even at subtherapeutic doses.

Authors:  Cory A Massey; George B Richerson
Journal:  J Neurophysiol       Date:  2017-07-26       Impact factor: 2.714

4.  Therapeutic effect of Thymoquinone on behavioural response to UCMS and neuroinflammation in hippocampus and amygdala in BALB/c mice model.

Authors:  Sadia Nazir; Rai Khalid Farooq; Sadia Nasir; Rumeza Hanif; Aneela Javed
Journal:  Psychopharmacology (Berl)       Date:  2022-01-14       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.